Susquehanna International Group, LLP Heron Therapeutics, Inc. Put Options Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 15, 2024	BUY	$2.32 - $3.86 $122,727 - $204,194	52,900 Added 79.43%	119,500 $418,000
Q1 2024 May 07, 2024	BUY	$1.71 - $3.06 $48,564 - $86,904	28,400 Added 74.35%	66,600 $184,000
Q4 2023 Feb 14, 2024	BUY	$0.54 - $1.82 $20,628 - $69,524	38,200 New	38,200 $64,000
Q2 2023 Aug 11, 2023	BUY	$1.11 - $2.88 $22,755 - $59,040	20,500 Added 155.3%	33,700 $39,000
Q1 2023 May 16, 2023	SELL	$1.51 - $3.25 $38,505 - $82,875	-25,500 Reduced 65.89%	13,200 $19,000
Q4 2022 Feb 14, 2023	BUY	$2.25 - $4.67 $8,100 - $16,812	3,600 Added 10.26%	38,700 $96,000
Q3 2022 Nov 14, 2022	BUY	$2.66 - $5.37 $47,614 - $96,123	17,900 Added 104.07%	35,100 $148,000

198

129M

94.7K

148K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $238M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.